Kunil

Kunil Pharmaceutical is a South Korean pharmaceutical company established in 1957, specializing in the development and commercialization of specialized medicines and generic drugs. The company is well-known for its focus on central nervous system (CNS) disorders, cardiovascular health, and respiratory conditions, notably marketing the prolonged-release melatonin product Circadin in Korea. Kunil operates with a strong emphasis on R&D through its research center and maintains a significant presence in the contract manufacturing sector through its subsidiary, Penmix. Its portfolio includes a variety of prescription drugs, including treatments for hyperlipidemia and insomnia, as well as over-the-counter products. The company has gained recognition for its fixed-dose combination (FDC) products, particularly those combining statins with omega-3 fatty acids.